placeUnited Kingdom
Contact & Support
Medtronic / Covidien Products / Therapeutic Endoscopy / Nexpowder™* Endoscopic Hemostasis System

Overview

New hemostatic powder technology: immediate hemostasis, low rebleeding rates, and minimal scattering or catheter clogging.

  • A proprietary powder coating technology that minimizes catheter clogging and particle scattering 
  • Unique delivery system that doesn’t rely on CO2 or air compressors
  • Distinctive blue color so you can have the confidence the lesion is fully covered
  • Highly adhesive gel that reacts to moisture, not just active bleeding, so it can be used in a variety of clinical applications

Maximum control. Minimal clogging. 

A hemostatic powder that puts you in control

When it comes to GI bleeds, time is of the essence. Don’t let clogged catheters or a cloudy field of vision slow you down.

Learn More

Clinical evidence, trainings and more

Learn more about the technology and clinical evidence behind Nexpowder™* , training opportunities, procedural information and much more.

Explore more resources on NexpowderTM

Nexpowder™* case video by Prof. Rath

Watch this Nexpowder™* case video by Prof. Rath, Head of the Ludwig Demling Endocscopy Center, University Hospital of Erlangen, Germany.

Watch the video

Would you like to learn more?

Visit GI HUB

Visit our GI HUB to learn more about our portfolio and healthcare solutions
Visit now

Contact us

Contact us to learn more about the clinical and patient benefits of the Nexpowder™* Endoscopic hemostasis system.
Contact us    

Indications and contraindications

Intended use

The Nexpowder™* endoscopic hemostasis system is used for most types of GI bleeding. The device is applied during an endoscopic procedure and can cover ulcer or bleeding sites. The device is not intended for use in patients with variceal bleeding.

Contraindications

Because the Nexpowder™* system includes lactose, it is contraindicated in patients who have galactose intolerance, lapp lactase deficiency, or glucose-galactose malabsorption and they would be at risk of having nausea, bloating, and diarrhoea. Because the Nexpowder™* system includes Brilliant Blue FCF, it must not be used in patients with known hypersensitivity to brilliant blue FCF.

  • ™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company

Corporate Resources
Medical Surgical Portfolio
Additional Resources
Contact Us
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2025 Medtronic